Introduction
Congenital myasthenic syndromes (CMS) are inherited disorders in which the safety margin of neuromuscular transmission is compromised by one or more specific mechanisms. The CMS recognized to date are attributed to an abnormality in the resynthesis or vesicular packaging of acetylcholine (ACh), a paucity of synaptic vesicles and reduced quanta1 release, end plate (EP) ACh esterase (AChE) deficiency, and postsynaptic defects associated with 2 kinetic abnormality or deficiency of the ACh receptor (AChR) (Engel, 1994) . We previously hypothesized that a kinetic abnormality of AChR predicts a mutation in one or more of its subunits (Engel, 1993; Engel et al., 1993) . Subsequently, we traced two CMS caused by prolonged AChR channel openings to 2 mutation in the M2 transmembrane domain of the E subunit (Ohno et al., 1995a (Ohno et al., , 1995b . To test our hypothesis further, we searched for the mutational basis of 2 slow-channel CMS (SCCMS) previously observed in two families and a sporadic case (Engel et al., 1982) . Here we report the discovery of a mutation in the a subunit gene of AChR in one of the SCCMS families and the sporadic case and analyze the pathogenic effects of the mutation on functional properties of AChR. The effects of the mutation on AChR function demonstrate the importance of ACh binding affinity in dictating the time course of the synaptic response. Moreover, the location of the mutation provides structural insight into determinan?s of ACh binding affinity.
Results

Electrophysiologic
Studies of SCCMS EPs from Patient 2 Miniature EP currents (MEPCs) recorded from SCCMS EPs were of normal amplitude but had 2 markedly prolonged decay (Figure 1 , upper traces). At all 11 EPs studied, the decay was biexponential, with one decay time constant 2.4-fold and the other a-fold prolonged (Table 1) . These observations indicate the presence of at least two kinetically distinct types of AChR at the SCCMS EP.
Power spectra of ACh-induced current noise were best fitted by the sum of two Lorentzians, one close to normal and the other 5-fold longer than normal, consistent with two open channel durations (Table 1) .
Patch-clamp recordings obtained from SCCMS EPs revealed markedly prolonged episodes of AChR channel openings over 2 range of ACh concentrations (50 nM to 10 PM; Figure 1 , lower traces). These channel events, like more than 99% of events at control EPs, had a mean conductance of 60 pS. Approximately 4% of events detected at SCCMS EPs had 2 reduced conductance of 45 pS and prolonged open durations typical of AChRs containing the y subunit instead of the E subunit (Mishina et al., 1986) . At 50 nM ACh, channel activity was uniformly distributed over the first 60 s of recording, but at higher concentrations, channel openings occurred in clusters separated by silent periods of 0.3-10 s, consistent with desensitization (Sakmann et al., 1980) . Control EPs, by contrast, showed no clear clustering of openings at concentrations up to I PM ACh.
Analysis of open interval durations revealed no differences between SCCMS and control EPs; a brief first and a longer second component had time constants and relative areas similar to those in normal controls ( Table 2) . Analysis of burst durations, however, revealed a markedly prolonged component of bursts at 6 of 7 SCCMS EPs, in addition to two brief components that were similar to those deiected in normal controls ( Table 2 ). The overall results from MEPC, ACh-induced current noise, and patch-clamp recordings indicate at least two types of AChR channels at the SCCMS EP: those that activate in episodes of ap- Note markedly prolonged decay of the MEPC and presence of some markedly prolonged channel events in the SCCMS. The MEPC decay phase is best fitted by the sum of two exponentials. Vertical arrows indicate MEPC decay time constants. MEPCs were filtered at 500 Hz and single-channel currents at 12 kliz. T = 22oc k 0.5% proximately normal duration and those that activate in markedly prolonged episodes.
Mutational Analysis
Patient 1, a familial case, and patient 3, a sporadic case, were previously described as patients 4 and 3 in the first description of the SCCMS (Engel et al., 1982) .
We first screened for the genetic basis of the SCCMS in patient 1 by single-strand conformation polymorphism (SSCP) analysis on amplified fragments of DNA encoding the a, 8, 6, and E subunits. We detected five aberrant conformers; four of these were commonly observed even in controls and were proven to be due to polymorphisms, but one was unique to the patient. Direct sequencing of the corresponding DNA fragments identified the four polymorphisms: 8A26G, predicting f3ESG, in 6 exon 2; 6A-52G, predicting SP-18P, in the signal peptide-encoding region of 6 exon 1; ~C857+15G in E intron 8, 15 bases downstream from the last base of exon 8; and ~C1233T, predicting ~A41 1 A, in E exon 11. The aberrant conformer unique to the patient was due to a heterozygous G to A mutation in a exon 5 at nucleotide 457 (aG457A) that converted the codon at position 153 encoding glycine to a codon encoding serine (aG153S) (Figure 2A ). The altered amino acid residue is in the amino-terminal extracellular domain of the a subunit, is unique to the a subunit, and is highly conserved among the a subunits of other species ( Figure 2C ).
The aG457A mutation resulted in gain of an Alul restriction site, allowing identification of carriers by analysis of PCR fragments derived from genomic DNA. Alul digestion of DNA samples obtained from other family members re- Table 1 . Analvsis of MEPCs and of ACh-Induced Current Norse vealed that all five affected and no unaffected relatives harbored the aG153S mutation. Thus, the aG153S mutation cosegregates with the SCCMS phenotype in the family ( Figure 28 ). Restriction analysis detected no similar mutation in DNA samples of 100 normal controls.
Restriction analysis of genomic DNA specimens obtained from 29 other unrelated CMS patients revealed another aG153S mutation, in a sporadic case of the SCCMS (patient 2 in this report). SSCP analysis of amplified DNA fragments of patient 2 revealed three aberrant conformers. On direct sequencing of the corresponding DNA fragments, one of the aberrant conformers proved to be due to the aG153S mutation. The second one was due to SA-52G, predicting 6P-18P, in 6 exon 1 (as in patient 1). The third aberrant conformer was accounted for by two polymorphisms in E intron 11: E1266+10del20 and EGO 266+33C.
To exclude the possibility that the aG153S mutation was only a linkage marker associated with an unidentified pathogenic mutation in the a subunit that SSCP analysis might have missed, we sequenced the entire open reading frame of the a subunit in both patients, using cDNA fragments of patient 1 and genomic DNA fragments of patient 2. No other mutations were detected.
Expression Studies
To confirm pathogenicity of aG153S and to allow studies of its mechanism of action, we engineered the mutation into the a subunit cDNA of mouse AChR and coexpressed the mutant a subunit with wild-type, 8, E, and 6 subunits in 293 HEK fibroblasts. Measurements of a-bungarotoxin binding revealed approximately 50% of surface AChR expressed by the mutant subunit relative to the wild-type subunit. We then recorded single-channel currents and measured binding of ACh to give an overall mechanistic description of the aG153S AChR. Values Indicate mean + SD; number of EPs indicated in parentheses. a For the 11 SCCMS EPs, the fast and slow components accounted for 48% + 5.7% and 52% -c 5.7% of the peak MEPC amplitude.
Patch Recordings from HEK Cells at Low ACh Concentrations
Figure 3 compares single-channel currents elicited by low concentrations of ACh (50-300 nM) for wild-type and aG153S AChRs expressed in 293 HEK cells. Currents were recorded at 12-14 kHz bandwidth to resolve the fine structure of opening and closing events. The wild-type Recordings from control EPs were in the presence of 1 PM ACh. ND, not detected. a The second component of bursts was present only at patches of 10 SCCMS EPs. Potential = -80 mV; T = 22OC + 0.5"C.
AChR opens from one to several times per activation episode, whereas the mutant AChR exhibits markedly prolonged activation episodes, apparently owing to increased numbers of openings per episode. This pattern of openings of the expressed mutant AChR is strikingly similar to that observed at the SCCMS EP (see Figure 1) . For both the wild-type and mutant AChR, closed duration histograms exhibit a long duration component associated with periods between independent activation episodes and a brief component associated with closely spaced openings of a single channel (Figure 3 ). Increased reopening of the mutant AChR gives rise to increased area of the brief closed duration component relative to that of the long duration component.
We constructed burst duration histograms by defining a burst as a series of openings separated by a specified closed time (100 KS for wild-type and 150 p.s for aG153S AChR; see Experimental Procedures). Both wild-type and mutant AChRs show two components of bursts ( Figure  3 ). The brief component corresponds to isolated single openings because its time constant issimilar in histograms of all openings and of bursts. These solitary openings may correspond to AChRs with a single bound agonist because their frequency of occurrence decreases at raised ACh concentrations (Colquhoun and Sakmann, 1985; see below (Colquhoun and Hawkes, 1981) . Using these relationships, b and km2 have been estimated from low concentration measurements for AChRs from several species (Colquhoun and Sakmann, 1985; Sine et al., 1990) . In the present work, both wild-type and mutant AChR show only one brief closed duration component at low ACh concentrations, so this component can be associated with dwells in the AR closed state. Table 3 summarizes measured parameters and computed rate constants for wild-type and mutant AChRs. The major effect of aG153S is to increase the number of brief closings per burst 15-fold, with only a 1.5-fold increase in the time constant of the brief closed time component. These measured parameters predict a decrease in the apparent kmp from 37,000 s-l to 2800 sP and no change in 8. The k-* estimate is "apparent" because it is not statistically weighted for the number of binding sites. In both wild-type and mutant AChFi, 8 is estimated to be very fast, 50,000-80,000 s-l, and is similar to that obtained from single-channel kinetic analysis of Torpedo AChR (Sine et al., 1990) and to that from fast ACh application experiments with mouse AChR (Liu and Dilger, 1991; Maconochic and Steinbach, 1992 , Biophys. Sot. Am. Sot. Biothem. Mol. Biol., abstract). The increased time constant of brief closings in the aG153S AChR thus results from a decreased rate of ACh dissociation. The channel closing rate a is only slightly decreased in the mutant, so the equilibrium constant for channel gating is not greatly affected. Thus, aG153S predominantly affects ACh binding steps; it decreases the rate of ACh dissociation from at least one of the two binding sites.
Patch Recordings at Raised ACh Concentrations
To determine the effect of aG153S on the remaining rate constants in scheme 1, we recorded currents at a series of raised ACh concentrations; these measurements also test consistency of 8, k-*, and a obtained from low concentration measurements. Raised ACh concentrations allow individual rate constants to be estimated because they cause events from a single channel to cluster into identifiable activation episodes (Sakmann et al., 1980) . Figure 4 shows an example of such a cluster from wild-type AChR in the presence of 20 uM ACh. At the start of the cluster, a single AChR channel has just recovered from the desensitized state and, during the cluster, makes transitions among activatable states. A desensitized state can be incorporated into scheme 1 as follows
where R and R' represent AChRs in the activatable and desensitized states, respectively, and M is their ratio in the absence of ACh, R'/R. The upper portion of scheme 2 is equivalent to scheme 1, except ACh is allowed to bind to the two sites independently. We use this more general treatment for analysis of recordings at high ACh concentrations because it accounts for a fourth closed duration component expected in cases in which the binding sites have neither identical nor widely separated affinities for ACh. The lower portion of scheme 2 depicts ACh binding to asingle high affinity desensitized state with dissociation constant KR,, which is consistent with the single affinity observed in our binding measurements (see below; see also Sine and Claudio, 1991) . At raised ACh concentrations, the AChR is predominantly desensitized because Kr+ is much smaller than dissociation constants for activatable states (i.e., k-,/k+, and k-2/k+2). Channel events cluster because transitions between the R and R' states are slow compared with transitions among R states. To compute transition rate constants between R states, we used standard Q-matrix methods to compute the probability of observing each experimental dwell time given a set of trial rate constants (Colquhoun and Hawkes, 1977; Ball and Sansom, 1989) . Optimal transition rate constants were taken as those that best described observed dwell times within clusters. Figure 4 shows clusters of openings from aG153S AChRs elicited by a range of ACh concentrations.
Openings cluster at concentrations as low as 0.3 uM, unlike openings of wild-type AChR, which begin to show clustering at about 5 uM ACh. As the concentration of ACh is increased, openings within clusters show progressively tighter packing, which is paralleled in the closed duration histograms where the major class of long duration closings moves to shorter time (Figure 4) . The open duration histograms, in contrast, do not change with ACh concentration, as expected from scheme 2. For comparison, we analyzed currents from wild-type AChR at the single ACh concentration of 20 uM (Figure 4 ) a concentration that produces clear clusters and allows occupancy of each activatable closed state.
To determine rate constants from scheme 2, the likelihood of obtaining each observed open and closed dwell time was calculated for a given set of trial rate constantsThe likelihoods were then summed over all events and maximized by iteratively changing the trial rate constants. For the aG153S AChR, essentially the same rate constants were obtained in every patch at every ACh concentration, so data obtained at all three raised ACh concentrations were analyzed together. For the wild-type AChR at 20 PM, some variation in rate constants was observed in different patches, requiring separate analysis of data from each patch. For analysis of the aG153S AChR, we allowed all six rate constants to vary, but for analysis of wild-type AChR, we found it necessary to hold f3 constant to the value obtained from the low concentration measurements (Table 3 ). The smooth curves overlying the histograms are probability density functions computed from the optimal rate constants determined by maximum likelihood fitting.
Analysis of recordings from the aG153S AChR yielded well-defined rate constants that describe open and closed duration histograms at all three ACh concentrations (Figure 4 ; Table 4 from single patches fitted according to scheme 2. For each type of AChfl, the smooth curves are fits to the data with rate constants given in Table 4 ; for aG153S, the curves are global fits to all the data. For wildtype AChR, the data and fitted rate constants correspond to the first patch in Table 4 , where k+, and km, are well defined. For wild type, the total number of openings and closings were 42,690 for this patch. For aG153S, total openings and closings for each patch were as follows: 0.3 PM, 3496; 1 nM, 5802; 10 PM, 434. log duration (s) discrete peaks, whereas at 10 PM, they are compressed into a major peak and a small, broad shoulder. A single dominant open duration component is observed at all three ACh concentrations, as predicted by scheme 2.
Analysis of recordings from wild-type AChR yielded well defined rate constants for one of the three patches at 20 PM ACh (Figure 4 ; Table 4 ). These rate constant estimates indicate significantly different affinities of the two binding sites for ACh, as previously described for AChRs containing they subunit (Sine et al., 1990; Zhang et al., 1995) . Analysis of data from the remaining two patches did not allow unique assignment of k,, and k-, (Table 4) although estimates of these constants obtained from the first patch predict a component in the other two patches that would be obscured by the major component of closed times. The major difference among patches appears to be k,,, which determines the position of the major peak of closed times and thus whether the less abundant briefer closed times that define k+, and km, can be distinguished from this major peak. Our estimates of k+? and kmP were well defined in each patch and indicate approximately a P-fold range of KD for wild-type AChR. Estimates of KP for the aG153S AChR lie well outside this range, indicating markedly increased affinity of ACh for this site (Table 4) .
The effect of aG153S on activation rate constants in scheme 2 is summarized in Table 4 . As demonstrated by analysis of recordings obtained at low ACh concentrations, the rate constant for ACh dissociation from one of the two binding sites is markedly slowed in aG153S. The sum of dissociation rate constants for the two sites (2237 s-') is close to the apparent rate constant obtained at low ACh concentrations (2810 s-'; Table 3 ) as expected. The experimental counterpart of this decreased kmP is the increased fraction of brief closings observed in all the data obtained over a wide range of ACh concentrations. Thus, in aG153S AChR, the rates of ACh dissociation from the two sites are slow and essentially equal, whereas in wildtype AChR, dissociation from at least one site is fast. Association rate constants are also affected by aG153.B increasing by approximately 1 O-fold (Table 4 ). The experimental correlates of faster association are closed time components with means of approximately 100 ms and 10 ms at 0.3 WM and 1 FM ACh, respectively, concentrations that produce much longer closed times in wild-type AChR. For both wild type and aG153S, estimates of the channel gating rate constants, 8 and a, are similar in both the high and the low ACh concentration analyses. Thus, as concluded from analysis of recordings obtained at low ACh concentrations, aG153S primarily affects ACh binding steps.
Measurements of Equilibrium ACh Binding
To gain an overall mechanistic picture of the effect of aG153S, we measured equilibrium binding of ACh bycompetition against the initial rate of a-bungarotoxin binding (Sine and Taylor, 1979) . aG153S shifts the concentration dependence of equilibrium ACh binding approximately 40-fold toward lower concentrations while maintaining cooperativity with a Hill coefficient of 1.45 ( Figure 5A ). Because both activatable and desensitized receptors contribute to equilibrium binding, we next measured the affinity of the desensitized receptor for ACh, with the aim of combining parameters of both activation and desensitization to describe equilibrium ACh binding.
Previous work established that local anesthetics convert the AChR to a state whose affinity coincides with that of the desensitized state (Weiland et al., 1977; Sine and Taylor, 1982) . We therefore measured ACh binding in the presence of a range of concentrations of the local anesthetic proadifen (Sine and Claudio, 1991) . For both aG153S and wild-type AChRs, 60-100 bM proadifen shifts the binding curve to lower ACh concentrations and decreases the Hill coefficient to unity, indicating binding to a single class of high affinity sites (Figures 58 and 5C ). We tested higher concentrations of proadifen to determine whether the shift was maximal but found no further shift of the curve. For wild-type AChR, the proadifen-induced shift is 55-fold, whereas for aG153S AChR, the shift is only 8-fold. Thus, for the aG153S AChR, the equilibrium binding curve lies closer to that for binding solely to the desensitized state. Taking the midpoint of each curve as KR' in scheme 2, the affinity of the desensitized state is seen to increase approximately 6-fold in aG153S (Table 4) .
The smooth curves overlying the equilibrium binding For each rate constant, the value in parenthesis is the error limit estimated by the half likelihood interval method (Colquhoun and Sigworth, 1983) ; rate constants without errors were fixed in the fitting. Rate constants not uniquely defined by the data are indicated by ND. Association rate constants are in units of uM-' s-', whereas all others are in s '. Kn, is the dissociation constant of the desensitized state for ACh, and M is the ratio of desensitized to activatable AChRs at rest. Values under Kn, and M are means and standard deviations. For the aG153.S AChR, the rate constants were determined from a global fit to the data from all four patches. Table 4 , KR. equal to GU,, for these data, and M = 1000. The curve through the open squares (no additions) is drawn according to scheme 2 with the activation parameters given in Table 4 (KI and Kz values of 2.5 and 914 uM, respectively), Kn equal to GU,, for the 100 aM proadifen data, and M determined by least squares fitting (Table 4) . The curve to the right represents the theoretical curve for binding solely to activatable states and is drawn according to scheme 2 with parameters given in Table 4 (K, and KP values of 2.5 and 914 FM, respectively) and M = 0. Because K, was uniquely determined for one of three patches (Table 4) we tested a range of KI values, and found values of 2 NM to 10 aM to fit the binding data equally well, with similar fitted values of M. (C) ACh binding to aG153S AChR in the absence and the presence of a saturating concentration of proadifen. The curve through the closed squares (+60 WM proadifen) is drawn according to scheme 2 with the activation parameters given in Table 4 (K1 and K2 values of 1.6 and 10.2 uM, respectively), KR. equal to KBqUll for these data, and M = 1000. The curve through the open squares (no additions) is drawn according to scheme 2 with the activation parameters given in Table 4 , Kn equal to G4., for the 60 aM proadifen data, and M determined by least squares fitting (Table 4) . The curve to the right represents the theoretical curve for binding solely to activatable states and is drawn according to scheme 2 with parameters given in Table 4 and M = 0.
profiles were obtained by fitting the theoretical binding function for scheme 2 to the binding data (Figures 56 and  5C ). Because the theoretical binding function contains too many parameters to allow a unique fit to the binding data alone (see equation 1 in Experimental Procedures), we assigned as many parameters as possible to values obtained from independent measurements. The activation parameters were assigned to values obtained from singlechannel kinetic analysis (Table 4 ) and the desensitization dissociation constant to that determined from the local anesthetic experiments. Thus, the only free parameter in the fit was the constant M, the ratio of desensitized to activatable AChRs at rest. Additional pathways between activatable and desensitized states can be incorporated into scheme 2 without affecting its applicability to binding data obtained at equilibrium; the equilibrium constants for these pathways would be defined, through microscopic reversibility, by the parameters shown in scheme 2. A distinguishing feature of scheme 2 is the concerted switch of the two binding sites from activatable to desensitized states, which gives rise to cooperativity in the equilibrium binding curve. For both wild-type and aG153S binding curves, both the midpoint and the degree of cooperativity are well described by scheme 2. The fitted M is a small number for both receptor types, but it increases about 50-fold in aG153S, indicating increased propensity for desensitization.
The increased propensity for desensitization by the aG153S AChR can be illustrated by defining a concentration window corresponding to the range of possible equilibrium ACh binding profiles. The right boundary of the window corresponds to occupancy of activatable states without desensitization, that is in the hypothetical case where M = 0 (smooth curves to the right in Figures 5B  and 5C ). The left boundary corresponds to occupancy of desensitized states without activation, that is with M very large (smooth curves through the binding data obtained in the presence of proadifen in Figures 58 and 5C ). For wild-type AChR, the small value of M causes equilibrium binding to lie near the right of the concentration window, closer to that for binding solely to activatable states ( Figure  58 ). For aG153S AChR, the window is slightly smaller, owing to increased affinity of ACh for activatable states. However, the major effect of aG153S is to cause equilibrium binding to skew toward that for binding to the desensitized state, owing to the larger value of M.
Discussion
The initial report of the SCCMS revealed prolonged decay of miniature EP potentials despite normal abundance and kinetic properties of AChE, leading to the proposal that the mean open time of AChR was prolonged (Engel et al., 1982) . The findings presented here confirm the original proposal by demonstrating prolonged activation episodes at SCCMS EPs and, further, establish aG153S as a primary cause of the syndrome by showing coincidence between the disease and the mutation and by reconstituting the diseased AChR phenotype in an expression system. Analysis of the expressed mutant AChR shows that its prolonged activation episodes arise primarily from a decreased rate of dissociation of ACh, allowing repetitive opening during ACh occupancy. Further, it is likely that an increased fraction of the mutant AChR will desensitize under conditions of raised ACh concentrations, such as during repetitive stimulation of the motor synapse in the presence of AChE inhibitors (Magleby and Pallotta, 1981) .
Patch-clamp recordings from the SCCMS EPs showed open intervals of normal duration at all ACh concentrations examined, but analysis of burst durations revealed an abnormally prolonged component of bursts. Pathogenicity of aG153S is therefore readily explained by increased reopenings of the AChR channel rather than by prolonged open channel intervals. Strikingly similar reopening behavior was observed in the aG153S AChR expressed in HEKcells, which can now be taken as a kinetic signatureof the increased ACh binding affinity caused by the mutation. Also, clustering of channel activation episodes at the SCCMS EPs at raised concentrations of ACh was similar to that observed with aG153S AChR in the expression system.
BecauseAChRsattheSCCMSEPscontain bothnormal and mutant a subunits, and because the two binding sites in the AChR are formed by as and a6 subunit pairs, as many as four types of AChRs could be present at these EPs. Differences in functional properties among these AChR types would be expected to introduce multiple components into the MEPC, ACh-induced noise, and singlechannel recordings presented here and may also contribute to differences in mean burst durations estimated by these different recording methods. For example, MEPCs decay with two detectable time constants of 8 ms and 26 ms at the SCCMS EP, but single-channel burst durations show means of 3.4 and 13.3 ms, and noise analysis shows time constants of 1.8 and 12.3 ms. The continuous presence of agonist in the single-channel and noise recordings may cause more strongly desensitizing AChR types to drop out early in the recording, decreasing their contribution to the distribution of burst durations and the noise spectrum. Thus, AChR channel events that decay slowly following transient application of ACh (MEPC) may be less apparent during steady-state application in single-channel and noise recording.
The key feature of the mutant AChR is its prolonged channel opening episodes. Analysis of these episodes at wide bandwidth revealed increased numbers of brief interruptions per episode with little change in the open time between interruptions.
Kinetic analysis of dwell times at low ACh concentrations disclosed rate constants for channel opening (8) closing (a), and ACh dissociation (k-& Of these rate constants, only kez was greatly affected by the mutation, decreasing approximately Idfold. We obtained similar estimates of 8 and kmp over a range of raised ACh concentrations, and our estimate of a very fast 6 for wildtype AChR is similar to that obtained by kinetic analysis of Torpedo AChR (Sine et al., 1990) and to that obtained by fast ACh application experiments with mouse AChR (Maconochie and Steinbach, 1992, Biophys. Sot. Am. Sot. Biochem. Mol. Biol., abstract). Our experiments at raised ACh concentrations indicated increased rates of ACh association in the mutant, resulting in a 1 OO-fold net increase in affinity for one of the two binding sites (K, in Table 4 ). Further evidence for enhanced ACh binding in the mutant was increased affinity of the desensitized AChR for ACh (KR in Table 4 ).
At first glance, the aG153S mutation appears structurally benign, despite conservation of G1.53 among a subunits and the absence of glycine in homologous positions of the 6, y, 6, or E subunits. aG153 could, however, affect ACh binding affinity by its proximity to aW149, one of four aromatic residues identified by affinity labeling and mutagenesis to contribute to agonist binding affinity (Dennis et al., 1988) . Containing only a hydrogen atom side chain, glycine can promote 6 turns and is part of a consensus sequence for terminating a helices (Aurora et al., 1994) . Through one or more of these structural contributions, aG153 may affect positioning of aW149. Mutation to serine may decrease local flexibility of the peptide chain or displace aW149 to allow improved interactions with agonist, thus increasing the rate of association and decreasing the rate of dissociation of ACh. It isof interest that aG153S appears to significantly affect only one of the two agonist binding sites, though it is present at both sites. This may be due to inherent differences in the binding sites caused by apposition of the a subunits to either the E or the 6 subunit.
The increased affinity caused by aG153S confirms the hypothesis that low ACh binding affinity is required for rapid termination of the synaptic response (Jackson, 1989) . According to the original description by Magleby and Stevens (1972) the decay of the EP current is due to properties intrinsic to the AChR rather than to removal of ACh from the synaptic cleft. The key intrinsic property is the duration of an activation episode following rapid binding and removal of ACh, which approximately equals the mean channel open time multiplied by the number of openings per activation episode, or (l/a)(l + f3/k-2) (Colquhoun and Hawkes, 1981) . Given avery fast 8 to provide rapid onset of the response, ke2 must be similarly rapid to limit the duration of the activation episode and thus allow repetitive generation of action potentials. Thus, the 15-fold decrease in km2 in the aG153S AChR causes a proportional increase in duration of the activation episode.
The aG153S mutation can have multiple effects on neuromuscular transmission.
First, there may be reduced expression of the mutant AChR; second, the prolonged EP currents cause cationic overloading and destructive changes at the EP (Engel et al., 1982) ; third, an increased fraction of the mutant AChR may become desensitized at physiological rates of stimulation (15-30 Hz) in the presence of AChE inhibitors (Magleby and Pallotta, 1981) ; and fourth, even during normal physiologic activity, the prolonged duration of the EP potential is likely to lead to their temporal summation and cause depolarization block of transmission.
It is of interest that the SCCMS caused by the aG153S mutation is less clinically disabling than the previously reported ~T264P and sL269F mutations that also prolong channel activation episodes (Ohno et al., 1995a (Ohno et al., , 1995b . However, perhaps owing to their location in the M2 transmembrane domain, cT264P and EL269F increase mean burst duration approximately 5-fold greater than aG153S which would cause more cationic overloading and explain why they are more deleterious than the aG153S mutation.
To date, mutational analysis and patch-clamp studies of CMS associated with prolonged open durations of AChR have revealed both genetic and phenotypic heterogeneity.
It is now clear that the duration of EP currents can be altered by mutations affecting either the gating mechanism directly or the affinity of ACh for its binding site. Finally, it is likely that other kinetically significant AChR subunit mutations causing CMS also exist, and that their study will yield further insights into structure-function relations of AChR.
Experimental Procedures
Clinical Data Patients 1 and 3 of this report were previously described as patients 4 and 3 in the first description of the SCCMS (Engel et al., 1982) . Patient 1, now 70 years old, had myasthenic symptoms since age 20. The family history is consistent with autosomal dominant inheritance through three generations. Patient 2 is the daughter of the affected brother of patient 1. She had myasthenic symptoms since age 3 but was undiagnosed until age 13. Patient 3 had myasthenic symptoms since age 34. His parents, five siblings, and two children were unaffected. Previous studies of intercostal muscle specimens in the SCCMS patients revealed an EP myopathy with degenerating junctional folds, EP AChR deficiency, abundant EP AChE, no kineticabnormality of muscle AChE, and normal to reduced amplitude and a prolonged decay of the miniature potential (Engel et al., 1982) . Control muscle specimens were obtained from patients without muscle disease undergoing thoracic surgery. All human studies were in accord with the guidelines of the institutional Review Board of the Mayo Clinic.
Electrophysiologic
Studies in Patient 2 An intercostal muscle specimen was used. All studies were done at 22°C ? 0.5%. MEPCs were recorded using a two electrode voltage clamp by standard methods (Magleby and Stevens, 1972) . MEPCs stored on videotape were low pass filtered at 500 Hz (-3 dB; 8 pole Bessel) and analyzed using an INDEC data acquisition and analysis system (INDEC, Sunnyvale, CA). MEPCs with <I ms rise times were accepted for analysis. The MEPC decay time constant was obtained from a computer fit of the curve y, = y&"' to the decay phase, where y0 is the peak amplitude, T is the decay time constant, and t is time. Analysis of ACh induced current noise was performed by standard methods: the mean duration of channel events was derived from the noise power spectrum (Anderson and Stevens, 1973) .
Patch-Clamp
Recordings from EP AChRs These were performed in the cell-attached configuration by a slight modification of the previously described method (Milone et al., 1994) . The bath and pipette solutions contained 135 mM NaCI, 5 mM KCI, 2 mM CaC&, 1 mM MgCI,, 15 mM NaHC03, 1.3 mM Na*HPO,, 11.1 mM dextrose (pH 7.2), with the pipette solution containing specified concentrations of ACh. For all patches, the membrane potential was set to -80 mV; when possible, recordings were also obtained at -40, -120, and -160 mV. These membrane potentials were achieved by applying a corresponding positive potential to the patch pipette and assuming a resting potential of 0 mV; a null resting potential was confirmed by the absence of detectable channel events with 0 mV applied to the pipette. Channel currents were recorded at 50 kHz using the Axopatch 200A amplifier (Axon Instruments, Foster City, CA), digitized at 100 kHz. stored on hard disk, and analyzed using pClamp 6 software (Axon Instruments) at a final bandwidth of 12 kHz. Burst durationsweredetermined bygroupingopeningsseparated byaspecified closed time (120-150 vs), which was taken as the intersection of the briefest closed time component with the next longer component. Open interval and burst duration histograms were plotted on logarithmic abscissa and fitted to the sum of exponentials by maximum likelihood (Sigworth and Sine, 1987) . mRNA and DNA Samples mRNA was obtained, using the Micro-FastTrack mRNA isolation kit (Invitrogen), from muscle specimens that had been stored under liquid nitrogen. First-strand cDNA was prepared from mRNA by using random hexamer primers with the cDNA Cycle kit (Invitrogen) and followmg the instructions of the manufacturer. Genomic DNA was isolated from blood lysate or from proteinase/SDS digest of muscle by phenolchloroform extraction followed by ethanol precipitation (Sambrook et al., 1989) .
PCR Primers
Published cDNA sequences of the human (x (Noda et al., 1963) , b (Beeson et al., 1989 ), 6 (Luther et al., 1989 , and E (Beeson et al., 1993) subunit were used to design cDNA primers. To amplify each exon and its adjacent splice donor and acceptor sequences from genomic DNA of each AChR subunit, we synthesized PCR primers according to intron sequences. For this, we used the known genomic sequence of the a subunit (Noda et al., 1983) but determined intron sequences of the b, 6, and E subunit genes first by using cDNA primers adjacent to putative introns predicted from genomic organizations in other mammals and then by sequencing the PCR-amplified intron regions. For the first exon of the p, 6, and E subunits genes, we used inverse PCR (Huang et al., 1990 ) to extend sequence information 5' to the translational start sites, and obtained S-end sequences for 142 bp of the 8, 196 bp of the S, and 562 bp of the E subunit genes (data not shown). This information enabled us to synthesize PCR primers to amplify each exon of the a, p, 6, and E subunit genes.
PCR Procedures PCR conditions for each primer were optimized by varymg Mg2' concentrationand pH and byaddition of 10%dimethylsulfoxideforamplifi-cation of G + C-rich fragments. The typical PCR reaction mixture included 60 mM Tris-HCI (pH 8.5), 15 mM (NH&S04, 1.5-2 mM MgCI,, 0.10-0.25 mM each dNTP, 0.8 KM each primer, with 100 ng of DNA and 1.25 U of Taq DNA polymerase (Perkin-Elmer/Cetus) in 50 ~1. cDNA fragments were amplified by the nested PCR procedure using l/50 of the first amplification product. The typical cycling protocol consisted of the following: first, denaturation at 94°C for 2 min; second, 35 cycles of 94"C for 30 s, 55°C or 60°C for 30 s, 72% for 3 min; and third. final extension at 72°C for 7 min.
SSCP Analysis
The cold SSCP procedure was employed (Hongyo et al., 1993) with about 500 ng of PCR-amplified DNA. Denatured SSCP samples were loaded on a 40/o-20% gradient polyacrylamide gel, electrophoresed at 12"C, stained with ethidium bromide, and examined under ultraviolet light.
Sequence Analysis PCR-amplified fragments of genomic DNA or cDNA were used for all sequencing procedures. PCR amplification products were purified by Wizard PCR Prep (Promega). All fragments were sequenced with an Applied Biosystems model 373A DNA sequencer using fluorescently labeled dideoxy terminators.
Restriction Enzyme Analysis A 155 bp fragments of genomic DNA spanning the aG153S mutation was amplified with primers 5'ATCATCGTCACCCACTTTCC-3'and 5'. AGTTGGAGACCCGAATCAC-3'.
The PCR product (25 ul) was purified by ethanol precipitation. Restriction enzyme digestion was carried out by incubating the purified PCR product, 2 pl of IO x reaction buffer (SURE/Cut A, Boehringer-Mannheim), and 5 U Alul (BoehringerMannheim) in a volume of 20 ~1 at 37% for 2 hr. The products were size-fractionated on a 4% agarose gel containing ethidium bromide,
Construction
and Expression of Wild-Type and Mutant AChR Mouse AChR subunit cDNAs were generously provided by Drs. John Merlie, Norman Davidson (a, 8, and S subunits; referenced in Sine, 1993) , and Paul Gardner (E subunit; referenced in Bouzat et al., 1994) and were subcloned into the CMV-based expression vector pRBG4 as described (Sine, 1993) . aG153S was constructed by first inserting a BamHl restriction site at codon 153 of the a subunit cDNA using PCR mutagenesis. The resulting construct was digested with BamHI, treated with mung bean nuclease, and a synthetic double-stranded oligonucleotide harboring the G153S mutation was used to bridge from a 5' Pstl site to the blunted BamHl site. The presence of the mutation and the absence of unwanted mutations was confirmed by dideoxy sequencing. Human embryonic kidneyfibroblast cells (293 HEK)were transfected with mutant or wild-type AChR subunit cDNAs using calcium phosphate precipitation as described (Bouzat et al.,1994) .
Patch-Clamp Recordings from AChRs Expressed
in HEK Cells Recordings were obtained in the cell-attached configuration (Hamill et al., 1981) at a membrane potential of -70 mV and at 22°C (Bouzat et al., 1994) . The bath and pipette solutions contained 142 mM KCI, 5.4 mM NaCI, 1.8 mM CaCI,, 1.7 mM MgCI,, and 10 mM HEPES buffer (pH 7.4). Because the aG153S AChR exhibited profound desensitization, single-channel currents at ACh concentrations greater than 300 nM disappeared within the first minute after forming the seal. We found, however, that depolarizing at f70 mvforafew minutes restored activity and allowed events to be observed on return to -70 mV. Thus, at 1 and 10 KM ACh for aG153S, recordings were obtained with intervening pulses to +70 mV. We consistently observed a similar voltage dependence for wild-type AChR at raised ACh concentrations, though less profound. Single-channel currents were recorded at 50 kHz using the Axopatch 200A, and digitized at 94 kHz with a PCM adapter (VR-106, Instrutech). For analysis of measurements at low ACh concentrations, data were transferred to a Macintosh computer using the program VCATCH, and analyzed using the program MacTAC (Instrutech) at a final bandwidth of 12-14 kHz. To measure closed times near the instrumentation dead time, the digitized points were interpolated to determine the exact time of crossing the detection threshold, and the observed duration at threshold was corrected according to the filter bandwidth (Colquhoun and Sigworth, 1983) . For recordings obtained at low ACh concentrations, dead times of 15.8 and 12.5 ns were imposed for filter bandwidths of 12 and 14 kHz, respectively. The resulting open and closed time histograms were plotted using a logarithmic abscissa and a square root ordinate (Sigworth and Sine, 1987) and fitted to the sum of exponentials by maximum likelihood. Burst durations were determined by grouping openings separated by a specified closed time (loo-150 ps), which was taken as the intersection of the briefest closed time component with the next longer component. For analysis of recordings at raised ACh concentrations, clusters of openings were first identified using a closed time 5 times longer than the predominant closed time component in the recording. Channel openings and closings within clusters were then detected using the Viterbi algorithm (Chung et al., 1990) ; for wild-type AChR at 20 9M ACh, recordings were filtered at IO kHz, and the imposed dead time was 25 tus; for aG153S AChR at 0.3 to IO PM ACh, recordings were filtered at 14 kHz and the dead time was 15 ps. Channel events were analyzed according to scheme 2 by an intervalbased maximum likelihood method that incorporated first order corrections for missed events (Roux and Sauve, 1985; see Zhang et al., 1995) .
ACh Binding Measurements At 3 days after transfection, intact cells were harvested by gentle agitation in PBS plus 5 mM EDTA. The esterase inhibitor 3,3-dimethylbutyl methylphosphofluoridate(1 pM)was added tothe PBSIEDTAsolution, and cells were incubated for 15 min. Cells were briefly centrifuged, resuspended in high potassium Ringer's solution, and divided into aliquots for ACh binding measurements. Specified concentrations Of ACh were added 30 min prior to addition of '251-labeled a-bungarotoxin, which was allowed to bind for 30 min to occupy at most half of the surface receptors. Unbound toxin was removed by washing twice with potassium Ringers solution containing 300 uM d-tubocurarine, followed by centrifugation, and radioactivity bound to the cells was measured with a gamma counter. Nonspecific binding'was determined in the presence of 300 pM d-tubocurarine. The initial rate of toxin binding was determined to yield fractional occupancy of sites by ACh (Sine and Taylor, 1979) . (1) where A is the concentration of ACh. term 1 = 1/2K1 + 112K2 + MI Kk., term 2 = 1/KIK2 + M/K!+? + 6/a/K,K2, K1 = k-]/k+,, and Kz = k-2/ ki2 (Sine and Claudio, 1991) .
